San Diego, CA (PRWEB) June 25, 2015
The Journal of Clinical Gastroenterology (July 2015) has published the results of a new sleep positioning study, which utilized MedCline™ to create and maintain an ideal sleep position for the treatment of GERD. The use of MedCline™ was shown to reduce esophageal acid exposure by 87% and reflux episodes by 38%, as compared to a traditional bed wedge. The study results confirm MedCline™ as an effective treatment for those who suffer with nighttime symptoms, such as heartburn and regurgitation.
The article is available on the Journal of Clinical Gastroenterology at: journals.lww.com/jcge/Abstract/publishahead/A_Novel_Sleep_Positioning_Device_Reduces.98453.aspx or via Pubmed at: http://www.ncbi.nlm.nih.gov/pubmed/26053170.
Though there have been many studies to assess the effects of an inclined position or a left-lateral position on the frequency and duration of acid reflux episodes, A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial is the first-ever study to evaluate the compounding benefits of combining these two positions.
In addition to this study, there are multiple studies currently underway which are utilizing MedCline™ to create and maintain an inclined, left-lateral position to effectively treat nocturnal GERD for different patient populations and clinical applications. For more information MedCline™ clinical trial result, contact Aaron Clark at 858-605-1747.
MedCline™ is a positional therapy device that provides at-home, on-demand relief of nocturnal acid reflux/GERD. By combining proper upper-body elevation with left-side lateral positioning, MedCline™ provides clinically proven symptom relief, while protecting the esophagus from damaging esophageal acid. MedCline™ is a Class I Medical Device available by prescription only.